लोड हो रहा है...
Forging a potent vaccine adjuvant: CpG ODN/cationic peptide nanorings
Type I interferon inducers may potentially be engineered to function as antiviral and anticancer agents, or alternatively, vaccine adjuvants, all of which may have clinical applications. We recently described a simple strategy to convert a Toll-like receptor 9 (TLR9) agonist devoid of interferon α (...
में बचाया:
| में प्रकाशित: | Oncoimmunology |
|---|---|
| मुख्य लेखकों: | , , , |
| स्वरूप: | Artigo |
| भाषा: | Inglês |
| प्रकाशित: |
Taylor & Francis
2014
|
| विषय: | |
| ऑनलाइन पहुंच: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4292235/ https://ncbi.nlm.nih.gov/pubmed/25610738 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/21624011.2014.950166 |
| टैग : |
टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!
|